'Does HPV affect my fertility?' Reproductive concerns of HPV-positive women: a qualitative study

被引:13
|
作者
Qaderi, Kowsar [1 ]
Mirmolaei, Seyedeh Tahereh [1 ]
Geranmayeh, Mehrnaz [1 ]
Farnam, Farnaz [1 ]
Sheikh Hasani, Shahrzad [2 ]
机构
[1] Univ Tehran Med Sci, Sch Nursing & Midwifery, Reprod Hlth Dept, Eastern Nosrat St,Tohid Sq, Tehran 141973317, Iran
[2] Univ Tehran Med Sci, Imam Khomeini Hosp Complex IKHC, Gynecol Oncol Dept, Tehran, Iran
关键词
Reproductive health; Qualitative research; Fertility; Female; Warts; Human papillomavirus; Iran; Papillomavirus infection; Pregnancy outcome; Sexually transmitted diseases; HUMAN-PAPILLOMAVIRUS; INFECTION; IMPACT; TRANSMISSION; EXPERIENCES;
D O I
10.1186/s12978-021-01126-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Reproductive health changes can occur following infection with Human papillomavirus. HPV is the most prevalent sexually transmitted infection causing a variety of clinical manifestations ranging from warts to cancer. This study aimed to explore the reproductive concerns of women infected with HPV. Methods In this qualitative study, we used the conventional content analysis approach, with the aid of MAXQDA.10 software, to analyze data extracted from the face-to-face semi-structured interviews with 20 Iranian HPV-positive women (sampled by maximum variation purposive sampling). The accuracy of this research was ensured according to the four criteria proposed by Guba and Lincoln. Results Exploring participants' reproductive concerns, three main categories were identified from the interviews including concerns about fertility potential, pregnancy and non-pregnancy reproductive issues. HPV-positive women concerned about reduced female/ male fertility due to HPV, the impact of the HPV on the fetal health, adverse pregnancy outcomes such as miscarriage and preterm delivery, and mother-to-child transmission of HPV during breastfeeding. HPV-positive women with abnormal cytology results were anxious that becoming pregnant or taking hormonal contraception might worsen their abnormalities. Most married women were reluctant to use a condom. Participants requested further information about the potential reproductive risks of the HPV vaccine. They also wanted to know about the safety of HPV vaccine during pregnancy and breastfeeding. Conclusions HPV-positive women had some reproductive concerns that should be considered in the designing of educational-consulting interventions. Women need to be better understood and informed about the impact of HPV on their reproductive health. Health care providers may lack knowledge about these specific areas, and they could benefit from additional up-to-date information to address women's reproductive concerns.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Cytology Triage for HPV-Positive Postmenopausal Women in a Setting of Cervical Cancer Screening
    Chacko, Aparna
    Bidkar, Vishaka C.
    Acharya, Geeta
    Crasta, Julian
    DIAGNOSTIC CYTOPATHOLOGY, 2025, 53 (05) : 246 - 250
  • [22] Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study
    Ralf B. Uken
    Oliver Brummer
    Carolin von Schubert-Bayer
    Thomas Brodegger
    Ingo U. Teudt
    European Archives of Oto-Rhino-Laryngology, 2016, 273 : 1933 - 1942
  • [23] Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study
    Uken, Ralf B.
    Brummer, Oliver
    von Schubert-Bayer, Carolin
    Brodegger, Thomas
    Teudt, Ingo U.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (07) : 1933 - 1942
  • [24] Stratifying HPV-positive women for CIN3+risk after one and two rounds of HPV-based screening
    Veldhuijzen, Nienke J.
    Polman, Nicole J.
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (08) : 1551 - 1560
  • [25] Management of high-risk HPV-positive women for detection of cervical (pre)cancer
    Luttmer, Roosmarijn
    De Strooper, Lise M. A.
    Steenbergen, Renske D. M.
    Berkhof, Johannes
    Snijders, Peter J. F.
    Heideman, Danielle A. M.
    Meijer, Chris J. L. M.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (09) : 961 - 974
  • [26] Prognosis of HPV-Positive Oral Squamous Carcinoma: A Cohort Study from Japan
    Goto, Mitsuo
    Hanai, Nobuhiro
    Nishikawa, Daisuke
    Nagao, Toru
    Hasegawa, Yasuhisa
    JOURNAL OF HARD TISSUE BIOLOGY, 2023, 32 (01) : 77 - 82
  • [27] Trimodality therapy for HPV-positive oropharyngeal cancer: A population- based study Trimodality therapy for HPV plus OPC
    Sanford, Nina N.
    Hwang, William L.
    Pike, Luke R. G.
    Lam, Allen C.
    Royce, Trevor J.
    Mahal, Brandon A.
    ORAL ONCOLOGY, 2019, 98 : 28 - 34
  • [28] Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study
    Hu, Ting
    Li, Kexin
    He, Liang
    Huang, Fanwei
    Yang, Fan
    Chen, Shimin
    Wang, Hui
    Ma, Ding
    Huang, Xiaoyuan
    Wu, Peng
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (03) : 309 - 318
  • [29] Microbiome markers in HPV-positive and HPV-negative women of reproductive age with ASCUS and SIL determined by V4 region of 16S rRNA gene sequencing
    Peremykina, Anastasiya
    Cheranev, Valery
    Krivoy, Andrey
    Andreev, Alexander O.
    Repinskaia, Zhanna
    Asaturova, Aleksandra V.
    Korostin, Dmitriy
    Rebrikov, Denis
    Bayramova, Gyuldana R.
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [30] Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study
    Batool, Sana
    Sethi, Rosh K. V.
    Wang, Annette
    Dabekaussen, Kirsten
    Egloff, Ann Marie
    Fitz, Catherine Del Vecchio
    Kuperwasser, Charlotte
    Uppaluri, Ravindra
    Shin, Jennifer
    Rettig, Eleni M.
    ORAL ONCOLOGY, 2023, 147